Influence of Fitzpatrick Skin Phototype and Body Mass Index on Non-invasive Optoacoustic Imaging
Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Aug 5, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how skin type and body weight affect the way our muscles get oxygen and blood flow during exercise. The researchers are using a new imaging technology called Multispectral Optoacoustic Tomography (MSOT) to see how different skin tones and body mass index (BMI) change the way our muscles respond when blood flow is restricted and during a simple toe-raising exercise. They will recruit healthy volunteers aged 65 to 74 with various skin tones and BMI to participate in the study.
To join the trial, participants must give their consent and be in generally good health. However, individuals who are pregnant, have diabetes, kidney problems, peripheral artery disease, muscle diseases, tattoos in the scanning area, or who do not provide consent will not be eligible. Participants can expect to undergo some exercises and then have scans done on their arms and legs to measure how well their muscles are getting blood and oxygen during the activities. This study will help us better understand how different factors influence muscle health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed informed consent
- Exclusion Criteria:
- • Pregnancy
- • diagnosed diabetes
- • diagnosed renal insufficiency
- • diagnosed Peripheral arterial disease
- • diagnosed muscle associated disease
- • tattoos in scan area
- • missing consent form
About University Of Erlangen Nürnberg Medical School
The University of Erlangen-Nürnberg Medical School is a prestigious institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. Renowned for its interdisciplinary approach, the medical school fosters collaboration among experts in various fields, enabling the development of cutting-edge therapies and treatment protocols. With a commitment to ethical standards and patient safety, the institution actively contributes to the global medical community by conducting rigorous clinical studies aimed at enhancing the understanding and management of diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Munich, Bavaria, Germany
Patients applied
Trial Officials
Ferdinand Knieling, PD Dr. med. habil.
Principal Investigator
Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported